Visioneering Technologies’ New Contact Lens Trial Shows Landmark Results in Slowing Children’s Nearsightedness
Completed three-year PROTECT randomized controlled trial finds NaturalVue Multifocal 1 Day contact lens slowed myopia progression by 1.06 diopters and eye elongation by 0.58 mm at 36 months.1,2 ANAHEIM, Calif. — Visioneering Technologies, Inc. (VTI), a medical device company that designs and markets specialty contact lenses, will announce completed three-year results from PROTECT, a prospective,…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
